Guido Parvis

1.2k total citations
27 papers, 437 citations indexed

About

Guido Parvis is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Guido Parvis has authored 27 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 14 papers in Genetics and 7 papers in Oncology. Recurrent topics in Guido Parvis's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Guido Parvis is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Guido Parvis collaborates with scholars based in Italy, United States and Sweden. Guido Parvis's co-authors include Giuseppe Saglio, Gianluca Gaïdano, Cristina Pastore, Gisella Volpe, U Mazza, Umberto Vitolo, Angelo Guerrasio, Barbara Botto, Davide Torti and Daniela Capello and has published in prestigious journals such as Blood, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Guido Parvis

26 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Parvis Italy 13 241 197 152 113 90 27 437
Nadine Juge‐Morineau France 12 250 1.0× 266 1.4× 149 1.0× 162 1.4× 227 2.5× 18 553
Jacob Haaber Christensen Denmark 13 233 1.0× 197 1.0× 243 1.6× 150 1.3× 149 1.7× 49 505
Vera Vanhentenrijk Belgium 12 374 1.6× 241 1.2× 219 1.4× 144 1.3× 50 0.6× 13 571
Junji Hiraga Japan 8 266 1.1× 185 0.9× 142 0.9× 119 1.1× 79 0.9× 17 464
Beata Holkova United States 13 297 1.2× 307 1.6× 139 0.9× 222 2.0× 155 1.7× 48 634
JG Gribben United States 5 285 1.2× 225 1.1× 161 1.1× 55 0.5× 112 1.2× 6 430
Parth Desai United States 12 295 1.2× 289 1.5× 189 1.2× 91 0.8× 73 0.8× 52 576
Julia Steinhilber Germany 15 392 1.6× 260 1.3× 235 1.5× 144 1.3× 107 1.2× 28 652
K. Adams United Kingdom 6 326 1.4× 261 1.3× 135 0.9× 56 0.5× 83 0.9× 8 520
Gottfried von Keudell United States 13 293 1.2× 243 1.2× 151 1.0× 179 1.6× 47 0.5× 46 560

Countries citing papers authored by Guido Parvis

Since Specialization
Citations

This map shows the geographic impact of Guido Parvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Parvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Parvis more than expected).

Fields of papers citing papers by Guido Parvis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Parvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Parvis. The network helps show where Guido Parvis may publish in the future.

Co-authorship network of co-authors of Guido Parvis

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Parvis. A scholar is included among the top collaborators of Guido Parvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Parvis. Guido Parvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carrà, Giovanna, Paola Circosta, Mara Brancaccio, et al.. (2019). Inhibition of bromodomain and extra‐terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia. Journal of Cellular and Molecular Medicine. 24(2). 1650–1657. 16 indexed citations
3.
Parvis, Guido, et al.. (2018). Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip. Hematology/Oncology and Stem Cell Therapy. 14(1). 76–81. 3 indexed citations
4.
Levis, Mario, Cristina Piva, Andrea Riccardo Filippi, et al.. (2016). Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 17(1). 14–22. 16 indexed citations
5.
Carrà, Giovanna, Cristina Panuzzo, Davide Torti, et al.. (2016). Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 16. S49–S50. 1 indexed citations
6.
Ruella, Marco, Andrea Riccardo Filippi, Riccardo Bruna, et al.. (2015). Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study. International Journal of Radiation Oncology*Biology*Physics. 94(4). 783–791. 29 indexed citations
7.
Filippi, Andrea Riccardo, Angela Botticella, Marilena Bellò, et al.. (2012). Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy. Leukemia & lymphoma. 54(6). 1183–1187. 23 indexed citations
8.
Ruella, Marco, Andrea Riccardo Filippi, Anna Russo, et al.. (2011). Rituximab Followed by Involved Fields Radiotherapy (IF-RT) in Stage I-II Follicular Lymphoma (FL): Long Term Results,. Blood. 118(21). 3699–3699. 2 indexed citations
9.
Saglio, Giuseppe, et al.. (2009). Molecular pathogenesis of diffuse large B-cell lymphoma. 2(7). 2 indexed citations
10.
11.
Pascale, A. De, et al.. (2006). Follow-up of mediastinal lymphoma: role of ultrasonography. La radiologia medica. 111(6). 759–772. 3 indexed citations
12.
Cardinale, Luciano, et al.. (2006). CT findings in primary pulmonary lymphomas.. PubMed. 110(5-6). 554–60. 6 indexed citations
13.
Vivenza, Daniela, Daniela Capello, Anna Migliazza, et al.. (2000). Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: Pathogenetic and histogenetic implications. Human Pathology. 31(7). 871–873. 18 indexed citations
14.
Vitolo, Umberto, Gianluca Gaïdano, Barbara Botto, et al.. (1998). Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients. Annals of Oncology. 9(1). 55–61. 79 indexed citations
15.
Volpe, Gisella, Barbara Gamberi, Cristina Pastore, et al.. (1996). Analysis of microsatellite instability in chronic lymphoproliferative disorders. Annals of Hematology. 72(2). 67–71. 2 indexed citations
16.
Gaïdano, Gianluca, Giuseppe Cimino, Cristina Pastore, et al.. (1996). Distribution ofTP53 mutations among acute leukemias withMLL rearrangements. Genes Chromosomes and Cancer. 15(1). 48–53. 12 indexed citations
17.
Volpe, Gisella, Barbara Gamberi, Cristina Pastore, et al.. (1996). Analysis of microsatellite instability in chronic lymphoproliferative disorders. Annals of Hematology. 72(2). 67–71. 29 indexed citations
18.
Pastore, Cristina, Josep Nomdedéu, Gisella Volpe, et al.. (1995). Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes Chromosomes and Cancer. 14(2). 106–111. 25 indexed citations
19.
Caligaris‐Cappio, Federico, et al.. (1992). Bone Marrow Microenvironment and the Progression of Multiple Myeloma. Leukemia & lymphoma. 8(1-2). 15–22. 29 indexed citations
20.
Caligaris‐Cappio, Federico, et al.. (1992). BCL-2 in B-Chronic Lymphocytic Leukemia. Current topics in microbiology and immunology. 182. 279–286. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine Juge‐Morineau Breakdown of academic impact, for papers by Jacob Haaber Christensen Breakdown of academic impact, for papers by Vera Vanhentenrijk Breakdown of academic impact, for papers by Junji Hiraga Breakdown of academic impact, for papers by Beata Holkova Breakdown of academic impact, for papers by JG Gribben Breakdown of academic impact, for papers by Parth Desai Breakdown of academic impact, for papers by Julia Steinhilber Breakdown of academic impact, for papers by K. Adams Breakdown of academic impact, for papers by Gottfried von Keudell
Rankless by CCL
2026